Addressing Biases in Analysis of Time of Infusion: NCI/SWOG Trial S1404 Among Participants With High-Risk Resectable Melanoma Who Received Adjuvant Anti-PD-1 Therapy.

Othus M, Truong TG, Sharon E, Kendra K, Grossmann K, Buchbinder E, Khushalani NI, Eroglu Z, Chandra S, Doolittle GC, Kirkwood JM, Ikeguchi A, Mihalcioiu C, Cowey CL, Reddy SA, Johnson DB, Taylor M, Sondak VK, Ribas A, Patel SP

Open source

DOI
10.1200/op-25-01413
Published
2026 Jun 23
Container
JCO oncology practice
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1200/op-25-01413,
  title = {Addressing Biases in Analysis of Time of Infusion: NCI/SWOG Trial S1404 Among Participants With High-Risk Resectable Melanoma Who Received Adjuvant Anti-PD-1 Therapy.},
  author = {Othus M and Truong TG and Sharon E and Kendra K and Grossmann K and Buchbinder E and Khushalani NI and Eroglu Z and Chandra S and Doolittle GC and Kirkwood JM and Ikeguchi A and Mihalcioiu C and Cowey CL and Reddy SA and Johnson DB and Taylor M and Sondak VK and Ribas A and Patel SP},
  year = {2026},
  journal = {JCO oncology practice},
  doi = {10.1200/op-25-01413},
  url = {https://doi.org/10.1200/op-25-01413}
}

RIS

TY  - JOUR
TI  - Addressing Biases in Analysis of Time of Infusion: NCI/SWOG Trial S1404 Among Participants With High-Risk Resectable Melanoma Who Received Adjuvant Anti-PD-1 Therapy.
AU  - Othus M
AU  - Truong TG
AU  - Sharon E
AU  - Kendra K
AU  - Grossmann K
AU  - Buchbinder E
AU  - Khushalani NI
AU  - Eroglu Z
AU  - Chandra S
AU  - Doolittle GC
AU  - Kirkwood JM
AU  - Ikeguchi A
AU  - Mihalcioiu C
AU  - Cowey CL
AU  - Reddy SA
AU  - Johnson DB
AU  - Taylor M
AU  - Sondak VK
AU  - Ribas A
AU  - Patel SP
PY  - 2026
JO  - JCO oncology practice
DO  - 10.1200/op-25-01413
UR  - https://doi.org/10.1200/op-25-01413
ER  - 

APA

M, O., TG, T., E, S., K, K., K, G., E, B., NI, K., Z, E., S, C., GC, D., JM, K., A, I., C, M., CL, C., SA, R., DB, J., M, T., VK, S., A, R., & SP, P. (2026). Addressing Biases in Analysis of Time of Infusion: NCI/SWOG Trial S1404 Among Participants With High-Risk Resectable Melanoma Who Received Adjuvant Anti-PD-1 Therapy.. JCO oncology practice. https://doi.org/10.1200/op-25-01413

Source records